Los programas de gestión de enfermedades y su aplicación a la enfermedad cardiovascular

Medicina Clinica

Volumn 113, Issue 18, 1999, Pages 704-709

  Rodríguez Artalejo, Fernando ^a,b   Banegas Banegas, José Ramón ^b   Guallar Castillón, Pilar ^b   Hernández Vecino, Ramón ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; FEMALE; FORWARD HEART FAILURE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK FACTOR;

ADULT; AGED; ALGORITHMS; CARDIAC OUTPUT, LOW; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK FACTORS;

EID: 0033610537     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. How to practice and teach MBE. Londres: Churchill Livingstone. 1997.
2. Haynes RB, Sackett DL, Gray JM, Cook DJ, Guyatt GH. Transferring evidence from research into practice, 1: the role of clinical care research evidence in clinical decisions. ACP J Club 1996; 125: 14-16.
3. Haynes RB, Sackett DL, Gray JM, Cook DJ, Guyatt GH. Transferring evidence from research into practice, 2: getting the evidence straight. ACP J Club 1997; 216: 14-16.
4. Gray JM, Haynes RB, Sackett DL, Cook DJ, Guyatt GH. Transferring evidence from researcn into practice, 3: developing evidence-based clinical policy. ACP J Club 1997; 126: 14-16.
5. Haynes RB, Sackett DL, Guyatt GH, Cook DJ, Gray JM. Transferring evidence from research into practice, 4: overcoming barriers to application. ACP J Club 1997; 126: 14-16.
6. Bretons Cuixart C, Permanyer Miralda C. La evaluación de resultados (outcomes) y de su relevancia clínica en cardiologia: especial referencia a la calidad de vida. Rev Esp Cardiol 1997; 50: 192-200.
7. Petitti DB. Epidemiologic issues in outcomes research. En: Brownson C, Petitti DB, editores. Applied epidemiology. Theory to practice. Nueva York: Oxford University Press, 1998; 249-276.
8. Rodríguez Artalep F, Figaredo Alvargonzález C, Hernández Vecino R. Investigación de resultados. En: Del Llano Señaris J, Ortún Rubio V, Martin Moreno JM, Millán Núñez-Cortés J, Gené Badía J. editores Gestión sanitaria. Innovaciones y desafíos. Madrid: Masson, 1998; 529-542.
9. Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996; 124: 832-837.
10. Hunter DJ, Fairfield G. Disease management. Br Med J 1997; 315; 50-53
11. Field MJ, Lohr KN, directors. Clinical practice guidelines: directions for a new program. Washington: National Academy Press, 1990.
12. Eccles M, Freemantle N, Mason J. Methods of developing guidelines for drug use in primary care. Br Med J 1998; 316: 1.232-1.235.
13. Field MJ, Lohr KN, directores. Guidelines for clinical practice: from development to use. Washington: National Academy Press, 1992.
14. Konstam M, Dracup K, Baker D, Bottorff MB, Brooks NH, Dacey RA et al. Heart failure: evaluation and care of patients with left ventricular systolic disfunction. Clinical practice guideline n. 11. AHCPR publication n. 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, junio de 1994.
15. Langley P. Disease management outcomes 1998. Financial times healthcare management reports. Londres: FT Healthcare, 1998.
16. Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. JAMA 1997; 278: 1.687-1.692.
17. Harris JM Jr. Disease management: new wine in new bottles? Ann Intern Med 1996; 124: 838-842.
18. Lawrence M, Williams T. Managed care and disease management in the NHS. What will be the role of the pharmaceutical industry? Br Med J 1996; 313: 125-126.
19. Vita AJ, Terry RB, Hubert HB, Fries JF. Aging, health risks, and cumulative disability. N Engl J Med 1998; 338: 1.035-1.041.
20. Daviglus ML, Liu K, Greenland P, Dyer AR, Garside DB, Manheim L et al. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to medicare costs. N Engl J Med 1998; 339: 1.122-1.129.
21. Maylor M, Brooten D, Jones R, Lavizzo-Mourey R, Mezey M, Pauly M. Comprehensive discharge planning for the hospitalized elderly: a randomized clinical trial. Ann Intern Med 1994; 120: 999-1.006.
22. Rich MW, Beckam V, Wittenberg C, Lever CL, Freedland KL, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1.190-1.195.
23. Weinberger M, Odcone E, Henderson WG. for the Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. Does increased access to primary care reduce hospital readmissions? N Engl J Med 1996; 334: 1.441-1.447.
24. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med 1998; 158: 1.067-1.072.
25. Ferguson JA, Weinberger M. Case management programs in primary care. J Gen Intern Med 1998; 13: 123-126.
26. Tanke ED, Leirer VO. Automated telephone reminders in tuberculosis care. Med Care 1994; 30: 380-389.
27. Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, Tekawa IS et al. Home blood pressure monitoring. Effect on use of medical services and medical care costs Med Care 1992; 30: 855-865.
28. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention. A system linking the physician, pharmacist, and computer. JAMA 1998; 280: 1.249-1.252.
29. DeBusk RF, Miller NH, Superko RH, Dennis CA, Thomas RJ, Lew HT et al. A case-management system for coronary risk factor modification after acute myocardial infarction Ann Intern Med 1994; 120: 721-729.
30. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA, on behalf of the Cochrane Effective Practice and Organization of Care Review Group. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J 1998; 317: 465-468.
31. Peiró S, Meneu R. Variaciones en la practica médica: implicaciones para la práctica clínica y la política sanitaria. Gac Sanit 1998; 12: 55-58.
32. Marion Buen J, Peiró S, Marquez-Calderon S, Meneu de Guillerna R. Variaciones en la practica clínica: importancia causas implicaciones. Med Clin (Barc) 1998; 110: 382-390.
33. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol 1997; 80: 45-52.
34. Chassin MR, Kosecoff J, Park RE, Winslow CM, Kahn KL, Merrick NJ et al. Does innappropiate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987; 258: 2.253-2.257.
35. Black N, Langham S, Petticrew M. Coronary revascularisation: why do rates vary geographically in the UK? J Epidemiol Community Health 1995; 49: 408-412.
36. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries N Engl J Med 1995; 333: 565-572.
37. Cowper PA, DeLong ER, Peterson ED, Lipscomb J, Muhlbaier LH, Jollis JG et al. Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators. Med Care 1997; 35: 320-333.
38. Cowper PA, Peterson ED, DeLong ER, Jollis JG, Muhlbaier LH, Mark DB. Impact of early discharge after coronary artery bypass graft surgery on rates of hospital readmission and death. The Ischemic Heart Disease (IHD) Patient Outcomes Research Team (PORT) Investigators. J Am Coll Cardiol 1997; 30: 908-913.
39. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1.569-1.582.
40. Velasco JA, Cosín J, López Sendón JL, De Teresa E, De Oya M, Carrasco JL et al. La prevención secundaria del infarto de miocardio er España. Estudio PREVESE. Rev Esp Cardiol 1997; 50: 406-415.
41. Ruilope LM, Aranda P, Coca A, Córdoba A, Gil V, Rodicio JL el al. Situación actual de la detección, tratamiento y control de la HTA en España Madrid: Liga Española para la Lucha contra la Hipertensión Arterial. 1995.
42. Paluzie G, Sans S, Puig T, Pérez I, Balañá L, Balaguer-Vintró I. Trends in awareness, treatment and control of hypertension in MONICA-Catalonia. Can J Cardiol 1997; 13 (Supl B): 340.
43. Coca Payeras A. Evolución del control de la hipertensión arterial en España Resultados del estudio Controlpres 98. Hipertensión 1998; 125: 298-307.
44. Aranda P, Villar J. Estudio epidemiológico andaluz sobre factores de riesgo vascular. Estudio Al-Andalus 90. Sevilla: Service Andaluz de Salud, 1993.
45. Banegas JR, Rodriguez Artalejo F, De la Cruz Troca JJ, Guallar-Castillón P, Del Rey Calero J. Blood pressure in Spain. Distribution, awareness, control and benefits of a reduction in average pressure. Hypertension 1998; 32: 998-1.002.
46. Brugulat P, Mercader M, Séculi E. La práctica de actividades preventivas en la atencion primaria y los objetivos del Plan de Salud de Cataluña 1993-1995. Aten Primaria 1998; 22: 334-339.
47. Block L. The design and implementation of a disease management program for congestive heart failure at a community hospital. Congestive Heart Failure 1997; 3: 32-37.
48. Maiques Galan A, Brotons Cuixan C, Villar Ȧlvarez F, directores. Guía de prevención cardiovascular. Madrid: Programa de Actividades Preventivas y de Promoción de la Salud-Sociedad Española de Medicina de Familia y Comunitaria, 1996.
49. Anderson KM, Wilson PWF, Odell FM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-362.
50. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1.837-1.847.
51. Wood D, De Backer G, Faergemar O, Graham I, Mancia G, Pyöräla K. Prevention of coronary heart disease in clnical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19: 1.434-1.503.
52. Rodriguez Artaleio F, Banegas Banegas JR, De Andrés Manzano B, Del Rey Calero J. Principios de la prevencion cardiovascular. Med Clin (Barc) 1999; 112: 459-464.
53. Bodenheimer T. Disease management promises and pitfalls. N Engl J Med 1999; 340: 1.202-1.205.